Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens
Keywords: Ecteinascidin-743; Objective response rate; Overall survival; Progression-free survival; Safety; Time to progression;